Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-12-14 | 2024-06-13 | 213368 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-12-14 | 2024-02-01 | 213371 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-12-14 | 2024-03-21 | 213374 |
TEVA-METOPROLOL | 100MG | TABLET | Resolved | 2024-01-11 | 2024-04-18 | 215701 |
REVIA | 50MG | TABLET | Resolved | 2024-01-11 | 2024-02-13 | 215710 |
TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-01-11 | 2024-03-18 | 215713 |
TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-11 | 2024-02-01 | 215716 |
TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2024-01-11 | 2024-03-18 | 215719 |
ACT QUETIAPINE | 200MG | TABLET | Resolved | 2024-01-11 | 2024-04-11 | 215725 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2024-01-11 | 2024-04-25 | 215728 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-11 | 2024-02-01 | 215731 |
ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-05-16 | 215737 |
TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-05-09 | 215740 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215743 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215746 |
TEVA-PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | TABLET | Resolved | 2024-01-11 | 2024-01-19 | 215757 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-01-18 | 2024-03-07 | 216457 |
TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-18 | 2024-05-09 | 216466 |
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2024-01-25 | 2024-03-18 | 217220 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2024-01-25 | 2024-05-09 | 217223 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |